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Flow cytometric analysis  of antigen-specific,  idiotype-positive (id+),  B  cell  development in 
transgenic mice expressing a rearranged M167-/~ gene shows that large numbers of phosphocholine 
(PC)-specific, M167-id + B cells develop in the spleen and bone marrow of these mice. Random 
rearrangement of endogenous Vx genes, in the absence of a subsequent receptor-driven  selection, 
should give rise to equal numbers of T15- and M167-id + B cells. The observed 100-500-fold 
amplification of M167-id + B cells expressing an endogenous encoded Vx24J.5 light chain in 
association with the M167 V.l-id transgene product appears to be an antigen driven, receptor- 
mediated process,  since no amplification of non-PC-binding M167 V.1/V~22, T15-id + B cells 
occurs in these/~-only transgenic mice. The selection and amplification of antigen-specific, M167- 
id + B cells requires surface expression of the ~  transgene product; thus, no enhancement of 
M167-id + B  cells occurs in the M167  /~Amem-transgenic mice, which cannot insert the/~ 
transgene product into the B cell membrane. Surprisingly, no selection  of PC-specific B cells 
occurs in M167-g-transgenic mice although large numbers of B cells expressing a crossreactive 
M167-id are present in the spleen and bone marrow of these mice. The failure to develop detectable 
numbers of M167-id + , PC-specific B cells in M167-K-transgenic mice may be due to a very low 
frequency of M167-V.-region formation during endogenous rearrangement of V.1  to D-J. 
segments. The somatic generation of the M167 version of a rearranged VH1 gene may occur 
in less than one of every 10  s bone marrow B cells, and a 500-fold amplification of this M167- 
Id + B  cell would not be detectable by flow cytometry even though the anti-PC  antibody 
produced by these B cells is detectable in the serum of M167-g-transgenic mice after immunization 
with PC. 
B  lymphocyte development in the mouse is a complex and 
dynamic process in which the adult bone marrow pro- 
duces "~6  x  107 new B cells each day (1). However, very 
few of these B cells appear to enter the stable, long-lived pe- 
ripheral B cell pool where the halfqife of a B cell, as mea- 
sured by bromodeoxyuridine (BrdUrd) incorporation, is 3 mo 
or longer (2, 3). It is of interest to understand how the few 
B cells that enter this long-lived pool are chosen from the 
millions of B cells produced each day. 
Analysis of the adult peripheral B cell V. repertoire (4-9) 
suggests that it is randomly generated in as much as it reflects 
the complexity of the V.  gene families  expressed  in  the 
mouse genome (8, 10); however, several studies (11-17) have 
also suggested that the peripheral B cell pool is selected and 
does not simply reflect the repertoire that emerges from the 
bone marrow. Yancopoulos et al. (11) found that the preferen- 
tial  utilization  of  J.  proximal  V.  genes  in  Abelson 
virus-transformed pre-B cells, which persists  in the bone 
marrow of adult BALB/c mice (9,  12), is not mirrored in 
the B cell repertoire of the adult spleen. Freitas et al. (9) have 
also found that local environmental factors can lead to in- 
creased representation  of the V.-J558 family in lymph nodes, 
while the V.-X24 family is overexpressed in Peyer's patches. 
The selection of individual idiotypes or H/L chain combina- 
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cell  ontogeny (15-17).  We have  shown (13, 14)  that T15 
idiotype-positive (id+) 1 B cells are functionally restricted to 
the Lyb-5 + B cell subset in normal mice, and that all phos- 
phocholine (PC)-specific B cells appear to be negatively selected 
via clonal deletion in M167 #/g anti-PC transgenic mice coex- 
pressing the xid gene (15). Other laboratories have suggested 
that T15-id + B cells are highly selected into the peritoneal 
CD5 + B cell subset (16, 17). The T15 (V.1/V~22) clone of 
B cells is the most frequently occurring individual B cell in 
the mouse (18). This overexpression  of the T15 clone may 
be due to antigenic (14) or antiidiotypic (19) selection and 
expansion during B cell ontogeny, although Klinman and 
Stone (20) have presented evidence that this preferential ex- 
pression  of T15-id +  B  cells  may be  reflected  even  at  the 
pre-B  cell level. 
To further address the problem of B cell selection during 
ontogeny, we have analyzed the development of PC-specific 
and M167-id + B cells in a series of #, g, and #/K transgenic 
mice (21). Storb et al.  (21) found that all strains  of M167 
#-only and some strains of M167 g-only transgenic mice ex- 
pressed high levels of endogenous V,M167 and V,1 mRNA, 
respectively. Many of these mice also exhibited elevated levels 
of circulating anti-PC antibodies. They suggested that this 
was due to activation of PC-specific B cells by environmental 
PC-containing antigens. Our results confirm those of Storb 
et al. (21) in that PC-specific, M167-id + B cells are expressed 
at a level 100-500-fold higher than expected in M167 #-only 
transgenic mice. In M167 g-only transgenic mice, more than 
two-thirds of their splenic B cells express the M167-idiotype; 
however,  these M167-id + B cells are not PC specific. The 
selection  and  overexpression  of M167-id +,  PC-specific  B 
cells in the #-transgenic mice appears to be an slg receptor- 
mediated phenomenon since it does not occur in #Amem- 
transgenic mice, which can not insert the # transgene product 
into the membrane of the B cell. 
Materials and Methods 
Animals.  Transgenic mice carrying the MOPC-167 (M167) # 
plus Ic transgenes (line 207-4, designation Tg[Igh  +  Igk]Bri12), 
the M167 #-only transgene  (line 243-4, designation  Tg [Igh]Bri35), 
the M167 K-only transgene (line 234-4 and 233-8, designation 
Tg[IgK]Bri34 and Tg[Igg]Bri161), and the M167/~Amem  (line  254-3, 
Tg[Igh]Bri37) were obtained from Dr.  U. Storb (University of 
Chicago, Chicago, IL) through Dr. R. L. Brinster (School  of  Veteri- 
nary Medicine, University of Pennsylvania, Philadelphia, PA) and 
have been described previously (21). These lines are maintained in 
our breeding colony by backcrossing transgene positive (TG § 
males to C57BL/6 female  mice. The progeny are typed for the pres- 
ence of the transgene by either ELISA of antibodies bearing the 
IgM  ~ allotype (/#), or by slot blot analysis of tail DNA (22). 
Antibodies.  The  rat  anti-V,l-id  hybridoma  T68.3,  which 
recognizes all antibodies carrying a V.1 heavy chain, and the anti- 
T15-id hybridoma T139.2 (23) were obtained from Dr. M. Scharff 
1  Abbreviations used in this paper: ABC, antigen-binding  cells; id, idiotype; 
ODN, oligodeoxynucleotide;  PC,  phosphocholine; RT,  reverse tran- 
scriptase; TG, transgene. 
(Albert Einstein College of Medicine, Bronx, NY). The rat anti- 
M167-id hybridoma 28-5-15 and 28-6-20 were produced by im- 
munizing with affinity-purified  MOPC-167 myeloma  protein (IgA, 
Jc24) and boosting with HPCM27 (IgM, K24) (24). The complete 
characterization of these and other anti-M167-id antibodies will 
be presented in detail elsewhere (Sieckmann et al., manuscript in 
preparation). In brief, antibodies  from clone 28-5-15 recognize  only 
the  M167 V.1-V~24 H/L chain combination  and  are  binding 
site-specific; i.e., binding to M167 antibody is blocked by PC, 
whereas, antibody 28-6-20 binds M167 and also binds three V,24 
antibodies having specificity for phenylphosphocholine and pos- 
sessing J558 V, H chains. Thus, this antibody recognizes a V~24- 
dependent crossreactive idiotope and it is not binding site specific. 
This antibody does not recognize the V~24 L chain in the absence 
of H chain. VK24 expression is a requirement for binding of both 
antibodies. These anti-id antibodies were affinity purified on pro- 
tein G-Sepharose and eluted with 0.1 M glycine-HC1 (pH 2.8). 
The eluate was neutralized with 1 M Tris buffer, pH 8.0, and dia- 
lyzed against 0.15 M NaC1. A rabbit polyclonal anti-T15-id an- 
tiserum was prepared as previously  described (25). The IgG1 anti- 
IgM  ~  allotype-specific  antibody (DS-1) (26) was obtained from the 
ascites of (C.B20  x  C57BL/6)F1 mice by ion exchange chroma- 
tography on DEAE-Sephacel equilibrated with 0.1 M Tris buffer, 
pH 8.5. The above mAbs were conjugated to biotin according to 
Titus et al. (27). FITC-conjugated goat anti-mouse # antibodies 
and PE-conjugated  streptavidin  were  purchased from Fisher  Scientific 
(Silver Spring, MD). Rat anti-~5 was a gift of Dr. Fred Finkelman 
(Uniformed Services University of the Health Sciences, Bethesda, 
MD). 
Flow Cytometric  Analysis.  Spleen  cells from TG + and TG- lit- 
termates were treated with NH4C1 (ACK) to remove RBC and 
adjusted to 107 cells/ml in HBSS containing 5% FCS. 100 #1 of 
cells (l&) was preincubated with anti-Fc receptor antibody (24G2) 
(28) and then incubated for 20 min on ice with 1 #g of FITC- 
and/or biotin-conjugated antibody. Cells were then washed twice 
with HBSS-5% FCS, resuspended  in 50 #1 of HBSS, and incubated 
for another 20 min on ice with 10/zl of PE-streptavidin. After two 
further washes with HBSS, the cells were analyzed on an EPICS 
753 cytofluorograph  for dual fluorescence  (Coulter Electronics, Hi- 
aleah, FL). Forward and right-angle light scatter and green (FITC) 
and yellow (PE) fluorescence were detected. Dead cells were ex- 
cluded from light scatter, and green fluorescence  analysis  was based 
on propidium iodide uptake. Compensation for spectral overlap of 
FITC and PE was determined using single-labeled samples. PC in- 
hibition of anti-id binding to spleen cells from M167 #/K 207-4 
transgenic mice was performed by staining cells as described above 
but in the presence of 5 x  10 -3 M PC (Sigma Chemical Co., St. 
Louis, MO). 
Antigen-binding  Cells  (ABC).  The number of spleen cells in 
TG § and TG- mice capable of binding PC was determined in a 
rosette  assay (29). SRBC  were conjugated  with diazophenyl- 
phosphocholine, as previously described (14), and adjusted to 2% 
(vol/vol). Spleen cells were diluted to 107/ml, and 200 #1 of spleen 
cells and 100 #1 of PC-SRBC were placed together in a 12  ￿  75 
tube, spun at 800 rpm for 10 rain in the cold, resuspended, and 
placed on a hemocytometer. The number of ABC was determined 
by counting the number of white cells having four or more PC 
SRBC bound. 
Isolation of M167-id § B Cells.  PC-specific,  M167-id  + splenic B 
cells were isolated from #-transgenic mice by staining them with 
FITC-conjugated anti-IgM  a and biotin-conjugated anti-M167-id 
(28-5-15) plus PE-conjugated streptavidin. The  double-positive 
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753 flow cytometer (Coulter Electronics). 
RNA  Isolation and PCR  Reactions.  RNA  from  2  x  106 
#ffM167-id  + spleen cells or M167-id  § (V.1/V~24) hybridoma cells 
from 207-4 transgenic mice were isolated using the guanidine 
thiocyanate-CsC1  centrifugation method (30). CsC1 was obtained 
from  Bethesda Research Laboratories (Gaithersburg, MD)  and 
guanidine thiocyanate from Fluka Biochemicals (Ronkonkoma, 
NY). For cDNA synthesis from RNA, 1.0 #g of total RNA was 
added to PCR reaction buffer (Perkin-Elmer Corp., Norwalk, CT) 
with final  concentrations of: 5 mM MgC12, 50 mM KC1, and 10 
mM Tris-HC1, pH 8.3.1 mM dATP, dCTP, dGTP, and dTTP was 
added to the mixture, as well as 1.0 #M 3' primer specific for C~ 
and 1 U of RNase inhibitor (Perkin-Elmer Corp.). The reaction 
mixture was heated to 65~  for 10 min, then placed  on ice. M-MLV 
reverse transcriptase (Bethesda Research Laboratories) was added 
to a final  concentration of 200 U/reaction and transcription allowed 
to proceed for 30 min at 37~  After cDNA synthesis, the reac- 
tions were incubated at 99~  for 5 rain and placed on ice. A PCR 
reaction was set up according to the instructions (GeneAmp RNA 
PCR kit;  Perkin-Elmer Corp.).  The PCR reactions contained 
cDNA, 2 mM MgC12, 50 mM KC1, 10 mM Tris-HC1, pH 8.3, 
2.5 U Taq Polymerase, 1.0 mM DTT, 0.2 mM dNTPs, and 0.2 
#M 5' and 3' primers. A thermocycler (Perkin-Elmer Corp.) was 
used for the amplifications.  The reactions were allowed to proceed 
for 30 cycles consisting of 90 s at 94~  90 s at 55~  and 150 s 
at 72~  A soak cycle  at the end of the 30 cycles at 72~  for 6 min 
terminated the reaction. 
Analysis of PCR Products.  20 ~I of the 100/~1 amplified prod- 
ucts was separated on 3% agarose gels containing 2.25% Nu-sieve 
GTG agarose (FMC  Bioproducts, Rockland,  ME)  and 0.75% 
regular agarose (Bethesda Research Laboratories), then stained with 
ethidium bromide and photographed. Only products of the size 
predicted by the locations of the primers within the KM167 and 
MOPC-21 sequences were present. IcM167 PCR products were se- 
quenced using the Sequenase 2.0 sequencing kit (U.S. Biochem- 
icals Corp., Cleveland,  OH) with the following modifications  (31): 
80/zl out of 100 #1 of the PCR product was extracted once with 
an equal volume of phenol/chloroform (1:1), then primers were 
removed by passage through a  Sepharose Cb6B  spin column 
(Boehringer-Mannheim  Biochemicals,  Indianapolis, IN). The final 
volume from the spin column was 80 #1. NP-40 was added to the 
sequencing reaction to a final concentration of 0.4%, 7/~1 of PCR 
product and 20 pmol of C~ primer were used. The reaction com- 
ponents were denatured by boiling for 3 min, then snap-cooled 
in powdered dry ice. The dGTP labeling mix was diluted 1:20, 
the sequenase enzyme 1:8. The labeling reaction was incubated at 
room temperature  for 2 min, and the termination  reaction  proceeded 
for 4 min at 37~ 
Oligodeoxynucleotide  Pr/men.  Unmodified  oligodeoxynucleotides 
(ODNs) were prepared by the Nucleic Add Synthesis Laboratory 
(Program Resources, Inc./DynCorp, NCI-FCRDC, Frederick, 
MD) using B-phosphoramidite chemicals on an automated DNA 
synthesizer (8750; Biosearch, Millipore, Milford, M.A). The ODNs 
were purified on denaturing polyacrylamide gels, electro-eluted, 
and ethanol precipitated. Concentrations were established by den- 
sitometry (Am of 1  =  20/~g). 
A V~ 167-specific 5' primer, MOPC-21-specific 5' primer, and 
C~  3'  primer  were synthesized using  the  published sequences 
(32-35) obtained  through computer databank searches. Primers  were 
selected from these sequences through the use of the PCR Primer 
Selection Program (Henry M. Jackson Foundation for the Advance- 
ment of Military Medicine, RockviUe, MD): V~M167 5' primer; 
5'-GCT-CCT-GAT-CTC-TTT-GAT-GTC-C-3'; V~M-21 5' primer: 
5'-AAT-GAC-CCA-ATC-TCC-CAA-ATC-C-Y; 3' C~ primer: 5'- 
GCC  -AT  T- TTG-TCG-TTC-ACT-  GCC  -  3  '. 
Transfection of V~ Genes into a V~-M167 Cell Line.  The J558L- 
M167# cell line was obtained from Dr. Carol Sibley (University 
of Washington, Seattle, WA). This cell line, which was produced 
by transfection of the J558L cell line with the p167# plasmid con- 
structed by Storb et al. (21), produces an IgM~ antibody that bears 
the V.l-id but does not bind PC (see Table 2). This cell line was 
then transfected  by electroporation (capacitance  of 960 #FD at 180 
V) with 10 #g of DNA from either the pSV2-Neo-S107-1c plasmid 
(provided by Dr. Phil Tucker, University of Texas, Dallas, TX) or 
the p1671c-plasmid (21) (provided  by Dr. Ursula Storb, University 
of Chicago, Chicago, IL) plus pSV2-Neo, and the resulting lines 
were selected  in the presence of Geneticin (microbiological  potency 
of 400 #g/ml) (Gibco Laboratories, Grand Island, NY). The anti- 
bodies produced by these cell lines were tested for the presence of 
T15-id and M167-id using the antiidiotypic antibodies described 
above, and they were also tested in ELISA for their ability to bind 
PC-BSA (36). 
Results 
Idiotype Analysis of Spleen Cells from M167/Z/K  Transgenic 
Mice.  We have previously shown that phenotypically normal 
M167/Z/K transgenic mice express the IgM  a (/Z*) transgene- 
encoded anti-PC antibody on 97%  of their splenic B cells 
(36).  When the spleen cells of these #/K TG + mice were 
stained with FITC-anti-# plus biotin-conjugated antiidiotypic 
antibodies, as shown in Fig.  1, >95% of the B cells stained 
with the H chain-specific  anti-V.l-id (A), and also with the 
H  +  L combinatorial anti-M167-ids 28-5-15 (C) and 28-6- 
20 (D). None of the B cells from these M167 #/K transgenic 
mice stained with anti-T15-id  antibody (B),  and <1%  of 
spleen cells from TG-  littermates stained with any of the 
anti-id antibodies (data not shown). Fig. 2 shows the staining 
of spleen cells from these same M167/Z/K transgenic mice 
with a combination of FITC-anti-#  a plus anti-id in the ab- 
sence (A-C)  and presence  (D-F)  of 5  x  10 -3 M  PC.  As 
previously shown by Desaymard et al. (23),  the binding of 
the T68.3 anti-V,l-id antibody to its idiotope is not blocked 
by PC (A vs. D). The binding of the crossreactive anti-M167-id 
28-6-20  is also unaffected by the presence  of PC (C vs. F), 
indicating that its idiotope is not in or near the binding site. 
On the other hand, the binding of the anti-M167-id anti- 
body from clone 28-5-15 to the M167-id + spleen cells is in- 
hibited by >90%  in the presence  of PC (B vs. E). 
Idiotype Analysis  of B  Cells from  M167 Iz-only Transgenic 
Mice.  The combined use of these anti-id antibodies allows 
us to follow the independent development of both H chain 
and H  +  L chain id § B cells and to quickly determine the 
frequency of those B cells that are also antigen specific. Using 
these anti-Id reagents, we have analyzed B cell development 
in transgenic mice carrying either the M167/z-only or d-only 
transgenes.  In the/z-only transgenic mice, the V.l-id will 
be  expressed  on  all  B  cells  expressing  the  #~  transgene 
product, while the 28-6-20  and 28-5-15 combinatorial idio- 
topes will be expressed  only on those B cells in which the 
/Z* transgene product  has  associated  with an  endogenous 
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Figure 1.  Idiotype analysis of spleen cells from M167 
I~/r 207-4-transgenic  mice. Spleen cells from 207-4- 
transgenic mice were stained with 1/zg each of FITC- 
conjugated  anti-/x and biotin-conjugated anti-id plus 
PE-streptavidin as described in Materials and Methods. 
The stained cells were then analyzed on a EPICS 753 
cytofluorograph  (Coulter  Electronics)  as previously  de- 
scribed (36). 
germline M167  (V~24) light  chain.  Since there is  only a 
single copy of the M167 V,24 L chain gene in the mouse 
genome (34), and this V, gene must rearrange to a J~5 gene 
segment to produce the M167 K L chain (37),  these M167 
combinatorial idiotopes should occur in ~0.1%  (1/800) of 
the/z~+  B cells.  This estimate is based on the assumption 
that the 100-200 endogenous K genes (38) are expressed in 
a random fashion and randomly rearranged to the four func- 
tional J, genes during transgenic B cell development. This 
estimate represents the upper limit for M167 V~24:J~5 ex- 
pression in as much as V, rearrangement is not completely 
random (39) and J,5 is under expressed in adult spleen (40). 
Spleen cells from/z-243-4 transgenic mice were stained with 
FITC-conjugated  goat  anti-/z  or  anti-/z  a,  and  biotin- 
conjugated  anti-V.l-id,  anti-T15-id,  or  anti-M167-id  fol- 
lowed by PE-streptavidin. Fig. 3 A  shows that 14% of the 
spleen cells or 28%  of the B cells in this mouse expressed 
the transgene-encoded H chain. The expression of the M167 
/Z transgene product is highly variable (25-80%) on B cells 
from 243-4 mice, and >50%  of these/Z'+  B ceils also ex- 
press the endogenous/zb allotype (Kenny et al., manuscript 
in preparation). The data in Fig. 3 B show that none of the 
B cells in these M167/z-only transgenic mice express the T15- 
id.  Formation of a T15-id + B cell would require that the 
V,1 transgene associate with an endogenous V,22 L chain, 
and this should occur at the same frequency ("~0.1%) as the 
generation of M167-id + B cells. By contrast, ~20% of the 
total B cells in this mouse express both the 28-5-15 binding 
site-specific and the crossreactive 28-6-20 M167-ids (Fig. 3, 
C and D). When one considers only the V,1 + B cells, these 
V,24-dependent M167-ids are expressed on 57%  and 71% 
of the TG + B cells, respectively. This is significantly higher 
(500-fold) than the 0.1%  M167-id + B cells expected from 
random expression of endogenous K genes. Two distinct M167- 
id + B cell populations are present, one with high levels of 
M167-id (5% of spleen cells) and one with low levels of M167- 
id (3-5%) (Fig.  3, C  and D). Three color flow cytometric 
analyses will be needed to determine if the low M167-id ex- 
pression is due to B cells expressing high levels of endoge- 
nous/zb allotype. The majority of M167-id bright cells are 
expressing only the/Z' transgene product, but some coex- 
pression of endogenous/z  b also  occurs in this  population 
(data not shown). 
Idiot~e Analysis of the Bone Marrow B Cells in MI67 ~z-only 
Transgenic Mice.  The above data indicate that splenic B cells 
expressing the V,I transgene product in association with a 
V,24 L chain have been selectively amplified at least 500-fold 
over the level expected from random association of H  and 
L chains. We therefore analyzed bone marrow B cells for M167- 
id expression  to determine whether this amplification of id + 
B cells also occurs during early B cell ontogeny or mainly 
reflects selection and amplification of these B cells in the pe- 
ripheral lymphoid tissues.  In the five/z-only bone marrow 
samples analyzed, an average of 2.4  _+ 0.3% of the/Z~+V,1 + 
B cells also expressed the 28-5-15 binding site--specific  M167-id. 
In  these  same  five  mice,  10.6  _+  0.7%  of  the  splenic 
/Z~ +V,1 + B cells carried the M167-id. Thus, there is approx- 
imately a fivefold increase in M167-id + B cells in the spleen 
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Figure 2.  PC inhibition  ofantiidiotypic  antibodies. 
Spleen cells from  207-4 transgenic  mice  were stained 
with 1/~g each of FITC-conjugated  anti-/~= allotype 
and biotin-conjugated  anti-id  plus PE-streptavidin  in 
the presence and absence of 5 ￿  10 -3 M PC as de- 
scribed in Materials and Methods  and then analyzed 
as in Fig. 1. 
compared to the bone marrow of the same mouse, but the 
M167-id levels in the bone marrow are still 24-fold higher 
than expected if the H  and L chains were associating ran- 
domly. However, it is possible that many of these M167-id + 
bone marrow B cells could have reentered the bone marrow 
from the periphery. Forster et al.  (2) have recently shown 
that the vast  majority of ~ + bone marrow B cells do not 
appear to arise from the rapidly dividing pre-B cells, but ap- 
pear to represent long-lived, nondividing B cells that circu- 
late through the bone marrow. When the bone marrow of 
g-only 243-4 mice was stained with FITC-anti-~ and biotin- 
anti-V.l-id plus PE/streptavidin, "~50% of the V,1 + B cells 
also expressed  ~ (data not shown). In transgenic mice, this 
may represent a minimal estimate of recirculating TG + B 
cells, since the B cells that express the V.1 transgene product 
in the absence of endogenous IX or ~ may also be cycling back 
to the bone marrow. Thus, the elevated numbers of M167- 
id + B cells in the bone marrow are probably due to recircu- 
lation of mature peripheral B cells back to the marrow. 
Selective Amplification orB Cells Bearing the MI67-id Is De- 
pendent on Cell Surface Expression of the tx Transgene Product. 
Storb et al. (21) had observed that M167 K-mRNA was elevated 
in all the M167 #-only transgenic mouse lines they produced, 
whereas, mRNA for this L chain was not detected in M167 
#Amem transgenic mice where the transgene product could 
not be inserted into the B cell membrane. We have confirmed 
this  observation by  staining the  spleen ceils  from M167 
IxAmem 254-3 transgenic mice with FITC-anti-g plus biotin- 
anti-M167-id. As shown in Fig. 4,  none of the Ix+ B cells 
from these mice stained with either the binding site-specific 
28-5-15 or crossreactive 28-6-20 anti-M167-ids.  The selective 
amplification of M167-id + B cells in the 243-4 Ix-only mice 
would therefore appear to be a receptor-mediated event and 
possibly antigen driven as suggested by Storb et al.  (21). 
M167-id+  B  Cells  in  Ix-only Transgenic Mice  Are  PC 
Specifi~  To determine if the M167-id + B cells in the Ix-only 
transgenic mice were indeed antigen specific, spleen cells from 
TG §  and  TG-  mice  were  stained  with  the  binding 
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Figure 3.  Idiotype analysis of spleen  cells  from 
M167-/~  243-4-transgenic  mice.  Spleen  cells  from 
/~-only 243-4 transgenic mice were stained and ana- 
lyzed as in Fig. 1, 
site-specific  anti-M167-id 28-5-15 in the presence and absence 
Of 5  X  10-3 M  PC and also rosetted with PC-conjugated 
SRBC.  Greater  than  95%  of the  #+/M167-id +  B  cells 
shown in Fig.  3 C  were PC inhibitable  (data not shown), 
and 5% of the #-243-4 spleen cells also formed PC-specific 
ABC in the rosette assay (Table 1). On the other hand,  the 
number of ABC in TG + #Amem 254-3 mice was no dif- 
ferent  than  that  seen in their  TG-  littermates. 
The spleen cells  from two strains  of M167 K-transgenic 
mice were also analyzed for PC-specific ABC. As shown in 
Table 1, there was no difference in the number of ABC de- 
tected in TG § and TG-  K 234-4 mice, whereas TG + K-233-8 
mice exhibited elevated numbers of ABC compared to their 
TG-  littermates.  However,  these  ABC  were  not  PC  in- 
hibitable and their exact specificity has not been determined. 
The data in Table 1 suggest that M167-id + , PC-specific B 
cells are highly expanded in #-only but not in either #Amem 
or K-only M167  transgenic  mice. 
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Figure 4.  Idiotype analysis of spleen 
cells from M167/z•Amem  254-3-trans- 
genic mice. Spleen cells from/~gAmem 
254-3-transgenic mice were stained and 
analyzed as described  in Fig. 1. 
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Percent ABC** 
Mouse  Transgene(s) 
strain  present  TG +  TG- 
243-4  ~  5.05  0.05 
254-3  ~Amem  0.04  0.03 
234-4  x  0.05  0.05 
233-8  K  2.40  0.45 
207-4  #K  46.0  0.04 
" Spleen cells from various strains of M167 transgenic mice were adjust- 
ed to 107 per ml; 200 #1 of spleen cells was rosetted with 100 #1 of 2% 
PC-SRBC  as previously described (15, 36). ABC were counted on a 
hemocytometer and the ABC data expressed as a percent of the total num- 
ber of spleen cells. The/~/x 207-4 mice were used as a positive control 
since >95% of their B cells have been shown to bind PC-SRBC (36). 
* The PC specificity of ABC was tested by rosetting in the presence of 
5  x  10 -3  M  PC.  Greater  than  90%  of the  ABC  in  the  243-4-/z- 
transgenic mice were inhibited by PC,  while none of the ABC in the 
233-8-x-transgenic mice were PC inhibitable. 
Antibodies Produced by the Association of the M167 #  Chain 
and the K22 L  Chain Are T15-id + but exhibit Low A~inity for 
PC.  At  least  three  L  chains  (V,8,  V~22,  and  V~24)  are 
known  to associate with  a V.I  gene product  to form PC- 
specific antibodies  (41).  Yet only the V.1/V~24  H/L  com- 
bination has been selectively amplified in the M167 #-trans- 
genie mice,  while  T15-id +  (Va1/V~22)  B  cells,  if present, 
are below the level of detection (Fig. 3). To determine whether 
or not the M167-# transgene product would form a PC-specific 
antibody when associated with a K22 L chain, we electropo- 
rated rearranged V~22 and V,24 L chain genes into a cell line 
containing  the M167/z  gene.  The antibodies  produced by 
these cell lines were tested for both id expression and for their 
ability to bind PC-BSA-coated plates. As shown in Table 2, 
the antibody formed by association of the M167-# H  chain 
and the V~22 L chain expresses the T15-ids detected by both 
the T139.2 monoclonal and rabbit polyclonal anti-T15 anti- 
bodies,  but  this antibody is at least  100 times less efficient 
at  binding  PC  than  the  T15 +  IgM  antibody  HPCM2, 
which was used as a control to generate the standard curves 
in  the  PC-specific ELISA.  On  the  other  hand,  the  M167- 
id § antibody formed by association of the M167-# transgene 
and the V~24 L  chain was PC specific and bound PC-BSA 
to the same extent as the control.  Yet antibodies formed by 
a V~24 L chain plus either an M603 or a T15 H  chain were 
M167-id + but not capable of binding PC (data not shown). 
These data suggest that the in vivo selection and amplification 
of M167-id + B cells in the #-transgenic mice is an antigen- 
driven rather than an antiidiotype-driven  event.  B  ceils ex- 
pressing the normally dominant T15-id + are not selectively 
amplified because the antibody product formed by the M167-# 
transgene  product  and  the  endogenous  V~22  L  chain  has 
little  or no  affinity for PC. 
Analysis of  the Endogenous K L Chain Expressed  in the M167- 
id + B Cells of #-transgenic Mice.  To demonstrate that the en- 
dogenous L chain expressed in the M167-id + , PC-specific B 
cells of #-transgenic mice was the product of an endogenous 
V~24-J~5  gene rearrangement,  the #a+/id + B cells shown in 
the upper right quadrant in Fig. 3 C were isolated by sorting 
them on the flow cytometer. RNA from these double-positive 
B  cells was PCR  amplified using a V~M167  5' primer and 
a Ca 3' primer.  RNA from the double-negative cells (lower 
left quadrant of Fig. 3 C), the MOPC-21 myeloma, two M167- 
id + hybridomas from #/K 207-4-transgenic mice, and a cell 
line expressing J558X//~-M167 were also PCR amplified using 
the M167 5' primer (Fig. 5 A). PCRs were carried out after 
Table  2.  The IgM T15-id  + Antibody Formed by M167-/z and V,22 Does Not Exhibit Good Binding to PC-BSA 
T15-id  M167-id 
Cell  Transfected 
line"  V  genes*  gs  ),  IgM  ~  VHl-id  T139.2  RdT15 li  28-5-15  28-4-3  PC-BSA 
J558L  +  V167~  -  +  +  + 
J558L  +  V167~  +  +  +  + 
+  V~22 
J558L  +  V167#  +  +  +  + 
+  VK24 
+  +  u 
+  +  + 
* The J558L-V167# cell line produces a V,l-id +  , IgMLX antibody that lacks the V~22- and V~24-dependent T15 and M167 idiotypes and does not 
bind PC. 
t When this cell line is transfected with either a V~22 or V~24 L chain gene, the resulting cell lines produce antibodies that express K and the ap- 
propriate T15 or M167 idotypes, respectively. 
S The total amount  of antibody bearing each of the above markers was determined in a capture ELISA in which plates coated with goat anti-# 
were developed by addition of biotin-conjugated antibodies specific for the indicated isotype, allotype, or idiotype as described in Materials and Methods. 
The same biotin conjugates were used to develop PC-BSA-coated plates. Standard curves were generated in all assays using either the IgM T15-id § 
hybridoma HPCM2 or the M167-id + IgM hybridoma HPCM27  (24). 
II Polyclonal rabbit anti-T15 ia antiserum (25). 
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id  + B cells from/z-only transgenic mice.  (A) PCR amplification using 
the M167~ 5' primer and C~ 3' primer. The correct  size of the PCtL 
product is 319 bp. Even-numbered lanes were amplified after mRNA was 
converted  to cDNA by RT, odd-numbered lanes are without RT.  Lanes 
I and 2, mR.NA from the MOPC-21 myeloma; lanes 3 and 4, from flow 
cytometry-sorted #~-/M167-id-  (double-negative)  cells; lanes 5 and 6, 
from the C47 M167-id + bybridoma line; lanes 7 and 8, from the J55L 
cell line transfected with the M167/L heavy chain; lanes 9 and 10, mRNA 
from double-positive (/~'+/M167-id +) cells; and lanes 11 and 12, from a 
second  M167-id +  hybridoma,  C46.  (B)  PCR  amplification using  the 
MOPC-21  5' primer and C~ 3' primer.  The correct  size of the PCR 
product is 466 bp. Even-numbered lanes, without K~ odd-numbered lanes, 
after RT. Lanes I and 2, amplification of mRNA from the double-negative 
cells; lanes 3 and 4, from MOPC-21; lanes 5 and 6, double-positive cells; 
and lanes  7 and 8, from the M167-id + hybridoma, C46. 
RNA was converted to cDNA by reverse transcriptase  (ILT; 
even-numbered  lanes), or without KT (odd-numbered  lanes). RNA 
from the double-positive cells amplified a product of the cor- 
rect size (319 bp) when the M167 5' primer was used (lanes 
9 and 10), proving that this population contained M167-1ike 
K  mRNA. A faint PCK product was also present after PCR 
amplification of the double-negative mRNA (lanes 3 and 4), 
and tLNA from both M167-id + hybridoma lines  (lanes 5 
and  6,  11  and  12)  amplified the  M167~-specific product. 
RNA from the J558~-/~M167 cell line and from MOPC-21 
did not amplify the K-167-specific product (lanes 7 and 8, 
1 and 2, respectively). The bands seen in lane 2 are at a higher 
molecular weight than the K-M167 product. 
To demonstrate that the #~+/M167-id + cells contained 
primarily M167-1ike K mRNA, a MOPC-21 5' primer was 
also used in conjunction with the C~ 3' primer to amplify 
mKNAs from this population of cells. In Fig. 5 B, PCK prod- 
ucts amplified from these primers are shown. No PCR product 
was seen in mRNA from the double-positive population (lanes 
5 and 6, plus and minus RT, respectively) or in the M167- 
id + hybridoma mRNA (lanes 7 and 8). MOPC-21 mRNA 
amplified a PCR product of the correct size (466 bp) (lanes 
3 and 4), and a band was also detectable in the PCR product 
of the double-negative cells on longer exposure or when more 
mRNA was used (data  not shown). 
All the VL genes expressed in PC-binding myelomas and 
hybridomas have been rearranged to the JK5 joining segment 
(37). The leucine at position 96-L is a contact-determining 
residue for PC (42),  and JK5 is the only J chain coding for 
leucine at this position. To demonstrate that the M167-1ike 
K mKNA expressed in the/z~+-M167-id + B cells represented 
a VK24 germ line gene rearranged to JK5, the mRNA from 
the  /~+/M167-id +  double-positive  B  cells  was  PCR 
amplified and the DNA product was sequenced from the 3' 
end using the C~-PCR primer.  RNA from a/~+/M167-id + 
hybridoma expressing the somatically mutated M167-K L chain 
was PCR amplified and sequenced as a positive control. The 
171-bp  sequence  obtained was  identical  to  the  published 
M167~ germ line sequence (34) over the last  103 bp of VL 
(i.e., starting with nucleotide 197, which is the last nucleo- 
tide of amino acid 61) (34), J~5, and 34 bp of C~ (data not 
shown). The DNA sequence obtained from the double-positive 
cells differed from that of the hybridoma sequence by two 
nucleotides (216 and 243) that are known to be somatically 
mutated in the M167-K L chain (34). 
Icliotype Analysis  of B  Cells  in  M167  d-only Transgenic 
Mice.  In M167 K-transgenic mice, the V~24 L chain should 
be expressed in all B cells, and endogenous K  L chains should 
be  suppressed  (43).  Thus,  the  combinatorial,  binding 
site-specific  28-5-15 V.1/V,24-dependent id recognized by 
the 28-5-15 antibody will be generated only when the en- 
dogenous V.I gene is rearranged to the DFL16.1  D  gene 
that has rearranged to a J.1 gene. If the single genomic copy 
of the endogenous V.1 gene (44)  is randomly rearranged 
during B cell development in K-only transgenic mice as it 
is in normal adult mice (4-9), then one should find '~0.006% 
(1/16,000) of the B cells in M167 K-transgenic mice expressing 
the binding site-specific  28-5-15 idiotope. This estimate is 
based  on the assumption that the mouse genome contains 
,'~200 V. genes, 20 D genes, and four J. genes. On the other 
hand, the M167 crossreactive 28-6-20-id could be generated 
by the association of the VK24 transgene product with a va- 
riety of endogenous V. gene products. 
All the data presented thus far indicate that the expression 
of the M167-/z transgene leads to a selective amplification 
of PC-specific B cells that coexpress the M167-endogenous 
L chain. However, the data in Table 1 suggest that PC-specific 
B cells are not selected in g-transgenic mice expressing  the 
M167-K chain. Since Storb et al. (21) have demonstrated that 
mRNA from both the K transgene and the secretory form 
of an endogenous T15 family gene are expressed at high levels 
in many of their M167-K-transgenic mice, it was important 
to determine whether large numbers of B cells in these mice 
were also expressing  these gene products as B cell surface 
receptors.  To analyze id development in M167 d-only trans- 
genic mice, spleen cells from 234-4 and 233-8 mice were stained 
with FITC-anti-/~  and the biotin-conjugated anti-ids as de- 
scribed above. The flow cytometric data shown in Fig. 6 dem- 
onstrate that splenic B cells bearing V.l-id, T15-id, or the 
M167 binding site-specific-id (28-5-15) were below the level 
of flow cytometric detection (A-C).  However,  as shown in 
Fig. 6 D, two-thirds of the B cells from TG + K-234-4 mice 
expressed the crossreactive,  28-6-20  M167-id  on their sur- 
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Figure 6.  Idiotype analysis of spleen cells from 
M167-K 234-4-transgenic mice. Spleen cells from 
234-4-transgenic mice were stained and analyzed  as 
described in Fig. 1. 
face, while 23% of the splenic B cells from g-233-8 mice ex- 
pressed this idiotype (data not shown). The IgM + B cells 
in the bone marrow of these mice also exhibited high levels 
of the crossreactive 28-6-20 id; 86% of the total IgM + cells 
in the single 234-4 mouse analyzed, and 16 and 22% of the 
total IgM + cells in the two 233-8 TG + mice analyzed. TG- 
mice always exhibited <1% M167-id § B cells in their bone 
marrow. These data suggest that the K transgene product is 
being expressed in association with endogenous #  chains in 
a large number of the B cells from these M167 K mice, but 
very few of these spleen cells express an endogenous M167-# 
H chain, which is required to produce a PC-spedfic antibody. 
Two populations of 28-6-20 M167-id + B cells are present 
in the x-only transgenic mice, one with high levels of id and 
one with low levels ofid (Fig. 6 D). This difference in M167- 
id expression is not due to a difference in density of IgM 
expression on the B cells but might be due to differences in 
IgD expression, or it could result from the coexpression of 
endogenous L chains, which would lower the intensity of 
M167-id staining. 
Discussion 
In this paper, we have presented data suggesting that there 
is a preferential selection and expansion of M167-id +, PC- 
specific B cells in transgenic mice that express a rearranged 
M167-H chain gene, and that a similar amplification of M167- 
id +, PC-specific B cells does not occur in mice expressing 
a rearranged M167 K transgene. In the M167-/x-transgenic 
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mice, 20-75%  of the splenic B cells expressing the/~' trans- 
gene  product  also  coexpress  an  endogenous  V~24-JK5 L 
chain. The frequency of expression of this H/L chain pair 
is 100-500-fold higher than the 0.1% frequency expected from 
a random expression and association of this or any other en- 
dogenous K L chain gene product with the M167-# trans- 
gene product.  The selective expansion of M167-id +,  PC- 
specific B cells in these/x-transgenic mice appears  to be the 
result an antigen-driven, receptor-mediated process; hence, 
it is dependent on the expression of the transgene product 
on the surface of the B cell, and it only occurs when the 
transgene-encoded H chain pairs with a light chain that confers 
PC binding specificity.  Thus,  there is no selection of PC- 
specific B cells in the M167-/~Amem-transgenic mice, which 
cannot insert the transgene-encoded antibody into their B 
cell membranes (22;  Fig. 4 and Table  1), and furthermore, 
there is no selection for T15-id + B cells  even though the 
M167-/~ chain can associate with a VK22 L chain to form 
T15-id + antibodies. The failure to selectively expand these 
T15-id + M167V,/V~22  B cells is probably due to the fact 
that they have little or no affinity for PC,  as was demon- 
strated in gene transfection studies (Table 2). On the other 
hand, the PC-specific V.1/V~24-expressing B cells are likely 
amplified in vivo via encounter with autologous or environ- 
mental PC in these #-transgenic mice. 
The observations presented in this paper may provide im- 
portant insights into how B cells in general are selected by 
antigen- or other receptor-mediated interactions from the 
short-lived pool of rapidly renewing bone marrow B cells into the long-lived  stable B cell population  that is present 
in peripheral lymphoid tissues. It would appear that the rap- 
idly renewing bone marrow B cells, like the majority of thymo- 
eytes, are destined to die within a few days unless they en- 
counter a ligand capable of signaling via their antigen-specific 
receptor. The B cells' encounter with ligand may have very 
different consequences depending on the developmental state 
of the B cell or the type of secondary signals concurrently 
generated by T cells or accessory  cells. Thus, we have recently 
shown (16) that PC-specific B cells are donally deleted in 
M167/z/r- and/z-only transgenic mice that coexpress the 
X-linked immunodeficiency gene, xid, whereas these same 
B cells are clonally expanded in normal mice. The clonal elimi- 
nation of PC-specific B cells in xid mice may occur because 
the xid B cell is unable to respond to soluble T cell or acces- 
sory cell signals (45), or because it remains in a developmen- 
tally immature, toleralizable state much longer than a normal 
B cell (46). The PC-specific B cells that develop in the bone 
marrow ofxid mice (15, 20) can be rescued from clonal dele- 
tion if they are provided with antigen and cognate T  cell 
help (Kenny et al., manuscript in preparation). 
The data presented in this paper support the idea that the 
PC-specific B cells that develop in normal mice are selectively 
expanded from the bone marrow in the long-lived peripheral 
B cell pool without specific  immunization, and we hypothe- 
size that this is because they can clonally expand when they 
encounter environmental or autologous PC in the presence 
of low levels of cytokines. Our observation that M167-id § 
B cells are expanded 100-500-fold in/z-transgenic mice while 
T15-id + B cells are not selectively expanded might also pro- 
vide insight into the reason for T15-id dominance in normal 
mice (18, 47-51). As shown in our transfection studies, both 
the V~22 and V~24 L chains can associate with the M167-/~ 
transgene product, and B cells expressing these endogenous 
genes should be generated at the same frequency in the bone 
marrow of the M167-/z-transgenic mice; however, the anti- 
body formed by M167-Hr22L  has little or no affinity for PC 
even though it expresses T15-id. According to our working 
hypothesis, B cells expressing this H/L chain pair would not 
be selected into the long-lived B cell pool because this selec- 
tion is an antigen-dependent, receptor-mediated  process. These 
data further suggest that an anti-id-induced  network selec- 
tion of T15-id + B cells is not operating in the M167-/Z- 
transgenic mice. In TG-  and other normal mice, T15-id + 
B cells may be expanded more than M167-id + B cells be- 
cause they have a higher affinity for PC (52, 53). However, 
as recently shown by Feeney and Thuerauf (53), the lower 
affinity M167-id  + B cells can dominate the immune response 
to PC in M167-r-transgenic mice where the K24 L chain should 
be expressed in every B cell and the r22 L chain should be 
suppressed by allelic exclusion. Our flow cytometry data on 
M167-K-transgenic mice demonstrate that M167-id +, PC- 
specific B cells are not expanded to the same degree as seen 
in the M167-/z-transgenic mice. In as much as the M167-id  + 
B cells generated in M167/z-only and r-only transgenic mice 
should have the same affinity, the lower number of PC-specific 
B cells in the K-transgenic mice must be due to the infre- 
quent generation of the rearranged endogenous M167-V,1 
gene, whose H chain product binds PC when associated  with 
the VK24 transgene product. The rearrangement of V.1 to 
DFL16.1/J.1  should occur in ~ol/16,000 B cells. If this en- 
dogenous V.1  H  chain always associated with the M167- 
g-transgenic  product to  form a PC-specific B cell in the 
g-transgenic mice and these B cells were expanded 100-500- 
fold, as they are in the M167-/z-transgenic mice, they should 
represent from 0.6 to 3% of the B cells in M167-K-transgenic 
mice. Since this frequency of M167-id + cells could easily be 
detected by flow cytometry, the probability  of forming a 
M167-H chain must be much less frequent. Feeney et al. (52, 
53) have demonstrated that most M167/M511 V.1 H chains 
have an alanine at position 96, which is needed to get good 
PC binding when associated with a V~24 L chain. The ala- 
nine at this position is generated by alternate slicing of the 
V.I gene or by N-region diversification, and additional so- 
matic changes also occur at the D-J junction in M167 H chains. 
By contrast,  the T15 form of the V,1 gene, which lacks the 
alanine at position 96, is generated entirely from germ line 
nucleotide sequences. During early neonatal development, 
when N-region diversification appears to play little or no role 
in  generating H  chain  diversity  (54), the  formation  of 
T15-VH1 sequences may be greatly favored over M167-V.1 
rearrangements. In the adult animal, the generation of M167- 
V.1  sequences will also be rare among all the variants of 
V,1-D-J.1  that can be generated by N-region diversification. 
In fact, Feeney (54) found no M167/M511 sequences among 
the  34  V,1  genes  PCR  amplified  from  an  adult  mouse 
spleen,  and Decker et  al.  (55) have estimated  that  >104 
unique sequences can be generated from a single V. gene 
segment rearranged in conjunction with a single J. segment. 
It is therefore not surprising  that large numbers of M167- 
id + B cells are not generated from rearrangement of the en- 
dogenous V.1 gene in the g-transgenic mice, although such 
cells exist in these mice and are activated after immunization 
(53). Large numbers of M167-id +, PC-specific B cells are 
produced in M167-#-transgenic mice because N-region diver- 
sity does not occur during the generation of the endogenous 
r repertoire, and one out of every four B cells that rearranges 
the germ line M167 V~24 gene segment will generate the 
V~24/J~5 L chain necessary for generating PC-specific B cells 
in conjunction with the M167-/Z transgene product. 
Even though PC-specific B cells are not generated in large 
numbers in the M167-K-transgenic mice, 20-80% of B cells 
present in these mice express the crossreactive M167-id. In 
the 233-8 line of M167-r-transgenic  mice, there were in fact 
increased  numbers of B cells that bound PC-conjugated SRBC, 
however, these ABC were not PC inhibitable. It is possible 
that  these  ABC  have specificity for nitrophenylphospho- 
choline (NPPC) in as much as the V~24 L chain has been 
shown to associate with V, genes from the J558 and 7183 
families to produce specific  antibodies (56). To detect binding 
site-specific  M167-id +  B  cells by  flow  cytometry, there 
would have to be >0.1% id + cells present in the spleens of 
the K-transgenic mice. Neither the M167-id detected by hy- 
bridoma 28-5-15 nor V,l-id + B cells were above the levels 
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to  detect elevated  levels of the  secretory form of V.-167 
mRNA in some of the M167-K-transgenic  mice using a $107 
V, family-specific probe.  Thus,  V,T15  family B  cells  are 
amplified and activated in the K-transgenic mice but not to 
a level detectable by flow cytometry. 
In conclusion, our data suggest that the expression  of the 
M167-# H chain in the B cells of transgenic mice results in 
an antigen-specific skewing of the B cell repertoire. A dis- 
proportionate number of the B cells of such animals express 
the M167-id and bind to PC. By contrast, when the same 
transgene product cannot be inserted into the cell membrane, 
the B cell repertoire is unaffected; there are no M167-id + 
cells detected by flow cytometry, and the PC response in the 
#Amem TG + animals is dominated by T15-id + B cells. The 
skewing of the repertoire in #-only transgenic mice appears 
to result from an antigen-driven rather than an antiidiotype- 
driven process.  The M167-# transgene product can form a 
T15-id + antibody by associating with an endogenous V~22 
L chain, but such an antibody does not bind to PC, and cells 
expressing such antibodies are not expanded in these mice. 
If the T15-id domination of the PC response in normal animals 
were based primarily upon id selection, we should have seen 
many PC-nonbinding T15-id + B cells in the #-only trans- 
genie mice. Data from the M167  K-only mice also support 
the conclusion that the repertoire selection is antigen driven. 
The V~24 L chain associates with the #  H  chain of many 
VH genes to generate a M167-crossreactive  id, but forms a 
PC-binding antibody only in the rare event that it associates 
with a particular alternatively spliced VHl-rearranged  gene 
product that generates an alanine residue at position 96. 
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